Authors' reply

Polskie Archiwum Medycyny Wewnetrznej

Volumn 124, Issue 11, 2014, Pages 640-641

  Zalewski, Jaroslaw ^a   Undas, Anetta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; LUPUS ANTICOAGULANT; RIVAROXABAN; THROMBIN INHIBITOR; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE;

ANTICOAGULATION; BLEEDING; BLOOD CLOTTING TEST; DRUG BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; INVASIVE PROCEDURE; LETTER; PARTIAL THROMBOPLASTIN TIME; THROMBIN TIME; BLOOD;

ANTITHROMBINS; BENZIMIDAZOLES; BETA-ALANINE; DABIGATRAN; HUMANS;

EID: 84916933343     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2511     Document Type: Letter

References (6)

1. Lippi G, Favaloro EJ. Urgent monitoring of dabigatran plasma levels: sometimes less is more. Pol Arch Med Wewn. 2014; 124: 639-640.
2. Lippi G, Ardissino D, Quintavalla R, Cervellin G. Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based on routine laboratory tests. J Thromb Thrombolysis. 2014; 38: 269-274.
3. Czubek U, Góralczyk T, Zalewski J, Undas A. Monitoring of anticoagulant effects of dabigatran in everyday practice: first experience in 32 Polish patients. Pol Arch Med Wewn. 2014; 124: 487-489.
4. Baglin T, Hillarp A, Tripodi A, et al. Measuring oral direct inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2013; 11: 756-760.
5. Huisman MV, Lip GY, Diener HC, et al. Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice. Thromb Haemost 2012; 107: 838-847.
6. Kornej J, Potpara T, Lip GY. Anticoagulation management in nonvalvular atrial fibrillation: current and future directions. Pol Arch Med Wewn. 2013; 123: 623-634.